News244d
Which of the breakthrough weight-loss medicines can you get in SA?
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...
Medscape8d
Some Patients — And Doctors — Turn to Microdosing GLP-1s
Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...
AllAfrica.com8d
South Africa: Which of the Breakthrough Weight Loss Medicines Can You Get in SA?
It is sold in two forms - Mounjaro and Zepbound - by United States (US ... Mounjaro is sold in pens containing 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg doses. Each pen contains a single-use dose and ...
HME News14d
ResMed moves to address ‘educational gap’ on PAP devices, GLP-1s
SAN DIEGO – In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep apnea, ResMed is ramping up its education to high-volume ...
Associated Press14d
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...
bnnbloomberg14d
Novo Nordisk Shares Have a Long Road Back from 40% Slump
The experimental CagriSema shot missed Novo’s own expectations for weight loss and performed roughly in-line with Eli Lilly & Co.’s Zepbound, which is already on the market and competes with the ...
MassDevice14d
ResMed revenue up 10% in Q2 — but GLP-1 questions remain
The results, out after market close yesterday evening, came more than a month after the FDA approved Eli Lilly’s GLP-1 drug Zepbound (tirzepatide) as the first and only prescription drug to ...
dermatologyadvisor14d
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
In December and January, the US Food and Drug Administration (FDA) approved new therapies for lung cancer, atopic dermatitis, obstructive sleep apnea (OSA), and cystic fibrosis. The FDA also added a ...
healthday15d
Weight-Loss Surgery Protects Liver Health
Similar findings also are possible for the new wave of anti-obesity drugs like Wegovy and Zepbound, given that they provide an average weight loss of 15% to 20%, researchers stated. People with ...
Nasdaq17d
What Does the Future Hold for Eli Lilly?
With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.
A drug got recalled after someone saw ‘black matter’ that can cause stroke or death
Provepharm said it pulled lot No. 24020027 with December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/mL after ...
BioWorld21d
Lilly’s Zepbound outpaces Wegovy as December logs 212 trial updates
Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.